Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus
- 1 October 2009
- journal article
- Published by Taylor & Francis Ltd in Expert Review of Gastroenterology & Hepatology
- Vol. 3 (5), 465-467
- https://doi.org/10.1586/egh.09.41
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver diseaseWorld Journal of Gastroenterology, 2009
- The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cellsCell Cycle, 2009
- Insulin receptor expression by human prostate cancersThe Prostate, 2008
- Insulin, insulin-like growth factors and neoplasiaBest Practice & Research Clinical Endocrinology & Metabolism, 2008
- Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004Hepatology, 2008
- The Growing Burden of Diabetes Mellitus in the US Elderly PopulationArchives of Internal Medicine, 2008
- The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in DiabetesDiabetes Care, 2006
- Diabetes increases the risk of chronic liver disease and hepatocellular carcinomaGastroenterology, 2004
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2004
- Nutrition, Insulin, Insulin-like Growth Factors and CancerHormone and Metabolic Research, 2003